Gastroenterology
Feature
Humira biosimilars: Five things to know
The launch of eight adalimumab biosimilars so far in 2023 ended Humira’s 20-year monopoly, but it’s not clear yet if these discounted drugs will...
ID Consult
Summer diarrhea – Time to think outside the box
While not an everyday diagnosis, waterborne parasites need to be in our summertime diarrheal differentials.
Latest News
What’s new in the new jaundice guidelines?
The neurotoxic risk factors and corresponding thresholds are important.
Letters from Maine
Home management of belly pain
For the most part, Dr. Moms and Dads are handling their children’s abdominal pain appropriately, but little is known about the rare and often...
From the Journals
AAP issues guidance on inguinal hernias
Among the findings is that laparoscopic surgery, which is increasingly popular for the hernias, is a safe and effective option.
News from the FDA/CDC
FDA approves first treatment for constipation in children
SBM frequency improved during the first week and was maintained throughout the remainder of the 12-week treatment period.
Livin' on the MDedge
The enemy of carcinogenic fumes is my friendly begonia
Also: Driving the gastrointestinal highway and pulling the plug on an unsupervised chatbot.
From the Journals
Sucralose damages DNA, linked to leaky gut: Study
The FDA says sucralose is safe, describing it as 600 times sweeter than table sugar and used in “baked goods, beverages, chewing gum, gelatins,...
Latest News
APA launches online eating disorder assessment tool
The tool guides clinicians through the screening, assessing, diagnosing, and treatment planning of patients with anorexia nervosa, bulimia nervosa...
News from the FDA/CDC
FDA approves Yuflyma as ninth adalimumab biosimilar
The manufacturer Celltrion is also seeking an interchangeability designation from the FDA, tentatively expected in the fourth quarter of 2024.
News from the FDA/CDC
FDA approves autoinjector pen for Humira biosimilar, Cyltezo
The drug will be commercially available on July 1, 2023.